Pharma-Bio Serv (PBSV) Income from Continuing Operations (2010 - 2026)
Pharma-Bio Serv (PBSV) posted Income from Continuing Operations of 232986.0 for Q2 2026, up 609.03% on a QoQ basis from 32860.0 in Q1 2026, and up 144.34% year-over-year from 95353.0 in Q2 2025.
Pharma-Bio Serv (PBSV) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 232986.0 for Q2 2026.
- Quarterly Income from Continuing Operations rose 144.34% year-over-year to 232986.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 51936.0 (up 127.45% YoY) and the FY2025 annual result came in at 100463.0, up 87.08% from the prior year.
- Income from Continuing Operations was 232986.0 for Q2 2026 at Pharma-Bio Serv, up from 32860.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 526242.0 in Q3 2023 and bottomed at 309194.0 in Q3 2024.
- A 5-year average of 94170.56 and a median of 64106.5 in 2025 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations slumped 163.48% — and 2026, when it jumped 284.96%.
- Pharma-Bio Serv's Income from Continuing Operations stood at 173379.0 in 2022, then plunged by 127.19% to 47148.0 in 2023, then soared by 134.17% to 16111.0 in 2024, then sank by 100.63% to 102.0 in 2025, then jumped by 228517.65% to 232986.0 in 2026.
- Business Quant data shows PBSV's Income from Continuing Operations at 232986.0 in Q2 2026, 32860.0 in Q1 2026, and 102.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 74.28 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 69.42 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | -13.47 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 35.13 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 43.28 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 19.11 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 3.71 Mn |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 | 232,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 232,986.00 |
| Jan 31, 2026 | 32,860.00 |
| Oct 31, 2025 | -102.00 |
| Jul 31, 2025 | -213,808.00 |
| Apr 30, 2025 | 95,353.00 |
| Jan 31, 2025 | 8,536.00 |
| Oct 31, 2024 | 16,111.00 |
| Jul 31, 2024 | -309,194.00 |
| Apr 30, 2024 | -213,817.00 |
| Jan 31, 2024 | -270,719.00 |
| Oct 31, 2023 | -47,148.00 |
| Jul 31, 2023 | 526,242.00 |
| Apr 30, 2023 | 404,654.00 |
| Jan 31, 2023 | 426,432.00 |
| Oct 31, 2022 | 173,379.00 |
| Jul 31, 2022 | 288,034.00 |
| Apr 30, 2022 | 240,027.00 |
| Jan 31, 2022 | 305,244.00 |
| Oct 31, 2021 | -4.87 Mn |
| Jul 31, 2021 | 2.28 Mn |